Chief Executive Officer
Carlos Orantes, Chief Executive Officer, has more than 25 years of experience in the life sciences, contract research, and drug development arena. He was most recently the CEO of Clinical Research Investments, which included Accel Clinical Research, Populace Health, Vitalis Research and Clinical Trial Connections as subsidiaries. Carlos’s prior experience includes leadership roles at Frontage Laboratories, AVANZA Laboratories, Bridge Laboratories, Gene Logic and Covance Laboratories.
Carlos earned his Bachelor of Science degree in Biology at George Washington University and his Master of Business Administration degree from Old Dominion University. He is also a Six Sigma Black Belt.